Digital biomarkers for fibrosis
IMVARIA is a health technology company specializing in AI-driven digital biomarker solutions, particularly for respiratory diseases like idiopathic pulmonary fibrosis (IPF). Founded in 2019 by physician-engineers from Google and Stanford University, IMVARIA develops software-as-medical-device (SaMD) tools designed to enhance clinical decision-making through non-invasive diagnostics.